Core Insights - Evolent Health reported a revenue of $468.72 million for the quarter ended December 2025, reflecting a year-over-year decline of 27.5% [1] - The company's EPS for the same period was $0.08, compared to -$0.02 a year ago, indicating a positive turnaround [1] - The reported revenue was slightly below the Zacks Consensus Estimate of $469.22 million, resulting in a surprise of -0.11%, while the EPS exceeded expectations by 28% [1] Financial Performance - Evolent Health's shares have decreased by 25.3% over the past month, contrasting with the Zacks S&P 500 composite's decline of only 1% [3] - The company currently holds a Zacks Rank of 3 (Hold), suggesting it may perform in line with the broader market in the near term [3] Key Metrics - Average PMPM Fees / Revenue per Case for Performance Suite was $13.87, slightly below the estimated $14.14 [4] - Average Lives on Platform for Cases reached 14 thousand, slightly above the estimated 13.86 thousand [4] - Total Revenue by product type for Performance Suite was $269.46 million, which is a 41% decline compared to the year-ago quarter [4] - Total Revenue by product type for Specialty Technology and Services Suite was $95.74 million, showing a year-over-year increase of 16.3% [4]

First Watch Restaurant Group, Inc. (FWRG) reported $316.35 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 20.2%. EPS of $0.24 for the same period compares to $0.01 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $315.11 million, representing a surprise of +0.39%. The company delivered an EPS surprise of +209.68%, with the consensus EPS estimate being $0.08.While investors scrutinize revenue and earnings changes year-over-year and ...

AMC Entertainment (AMC) reported $1.29 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of 1.4%. EPS of -$0.18 for the same period compares to -$0.18 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.28 billion, representing a surprise of +0.5%. The company delivered an EPS surprise of +7.69%, with the consensus EPS estimate being -$0.20.While investors scrutinize revenue and earnings changes year-over-year and how they compare with W ...

Core Insights - Tandem Diabetes Care, Inc. (TNDM) reported a revenue of $290.38 million for the quarter ended December 2025, reflecting a 15% increase year-over-year and a 5.21% surprise over the Zacks Consensus Estimate of $276 million. The EPS was -$0.01, significantly improved from -$0.44 in the same quarter last year, resulting in an EPS surprise of +80.51% [1] Financial Performance - The company’s pump shipments totaled 38,000, exceeding the average estimate of 35,032 by two analysts. In the U.S., pump shipments were 27,000, surpassing the average estimate of 25,632 [4] - Geographic sales in the U.S. reached $210.46 million, above the five-analyst average estimate of $203.09 million, but showed a year-over-year decline of -1.9%. Sales outside the U.S. were $79.92 million, significantly higher than the average estimate of $72.94 million, but represented a drastic year-over-year change of -99.9% [4] - Sales of pumps in the U.S. amounted to $111.49 million, exceeding the average estimate of $108.34 million, with a year-over-year increase of +13.3%. Sales outside the U.S. were $28.58 million, also above the average estimate of $26.16 million, reflecting a +10.9% year-over-year change [4] - Revenue from supplies and other in the U.S. was $98.98 million, surpassing the average estimate of $94.74 million, with a year-over-year increase of +15.2%. Outside the U.S., revenue was $51.34 million, exceeding the average estimate of $46.8 million, showing a +21.3% year-over-year change [4] Stock Performance - Shares of Tandem Diabetes Care have returned -8.7% over the past month, compared to a -0.8% change in the Zacks S&P 500 composite. The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - PowerFleet reported revenue of $113.49 million for the quarter ended December 2025, reflecting a 6.6% increase year-over-year and surpassing the Zacks Consensus Estimate of $111.73 million by 1.58% [1] - The company achieved an EPS of $0.02, a significant improvement from -$0.11 in the same quarter last year, resulting in an EPS surprise of 600% against a consensus estimate of $0 [1] Revenue Breakdown - Service revenue was reported at $91.09 million, exceeding the average analyst estimate of $90.11 million, marking an 11.4% increase compared to the previous year [4] - Product revenue reached $22.4 million, slightly above the two-analyst average estimate of $21.76 million, but showed a year-over-year decline of 9.3% [4] Profit Metrics - Gross profit from product sales was $7.09 million, surpassing the average estimate of $6.96 million [4] - Gross profit from service sales was reported at $55.6 million, which fell short of the average estimate of $57.03 million [4] Stock Performance - Over the past month, PowerFleet's shares have declined by 12.2%, contrasting with a minor decrease of 0.2% in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Group 1 - Regal Rexnord reported revenue of $1.52 billion for the quarter ended December 2025, reflecting a 4.3% increase year-over-year [1] - The company's EPS for the quarter was $2.51, up from $2.34 in the same quarter last year, with an EPS surprise of +1.7% compared to the consensus estimate of $2.47 [1] - The reported revenue was slightly below the Zacks Consensus Estimate of $1.54 billion, resulting in a surprise of -1.12% [1] Group 2 - Regal Rexnord's shares have returned +8.6% over the past month, outperforming the Zacks S&P 500 composite's +0.9% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3] Group 3 - Revenue from Automation & Motion Control (AMC) was $480.4 million, exceeding the average estimate of $458.75 million by four analysts, representing a year-over-year increase of +17.2% [4] - Revenue from Industrial Powertrain Solutions (IPS) was $669.3 million, slightly below the average estimate of $671.55 million, with a year-over-year change of +5.4% [4] - Revenue from Power Efficiency Solutions (PES) was $373.5 million, falling short of the average estimate of $410.23 million, reflecting a year-over-year decline of -10.3% [4] Group 4 - Adjusted EBITDA for Automation & Motion Control (AMC) was $98.6 million, surpassing the average estimate of $96.51 million [4] - Adjusted EBITDA for Power Efficiency Solutions (PES) was $58.2 million, below the average estimate of $60.65 million [4] - Adjusted EBITDA for Industrial Powertrain Solutions (IPS) was $171.7 million, slightly below the average estimate of $173.99 million [4]

Core Insights - Horace Mann reported revenue of $434.8 million for the quarter ended December 2025, reflecting a 6.3% increase year-over-year, but fell short of the Zacks Consensus Estimate of $443.7 million by 2.01% [1] - The company's EPS was $1.21, down from $1.62 in the same quarter last year, but exceeded the consensus estimate of $1.18 by 2.98% [1] Financial Performance Metrics - Net premiums and contract charges earned were $317.2 million, slightly above the average estimate of $314.07 million from two analysts [4] - Other income was reported at $6.7 million, surpassing the average estimate of $4.77 million based on two analysts [4] - Net investment income was $118 million, which was below the average estimate of $124.82 million from two analysts [4] Stock Performance - Over the past month, shares of Horace Mann have returned -1.4%, while the Zacks S&P 500 composite increased by 1.8% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - Aptiv PLC reported revenue of $5.15 billion for the quarter ended December 2025, reflecting a 5% increase year-over-year and surpassing the Zacks Consensus Estimate of $5.08 billion by 1.46% [1] - The company's earnings per share (EPS) was $1.86, an increase from $1.75 in the same quarter last year, and exceeded the consensus EPS estimate of $1.82 by 2.23% [1] Financial Performance Metrics - Net Sales- Eliminations and Other reported at $-212 million, significantly higher than the average estimate of $-144.22 million, marking a year-over-year change of +1313.3% [4] - Net Sales- Advanced Safety and User Experience reached $1.42 billion, slightly below the average estimate of $1.44 billion, with a year-over-year increase of +2.8% [4] - Adjusted Operating Income for Advanced Safety and User Experience was $161 million, compared to the average estimate of $174.86 million [4] Stock Performance - Shares of Aptiv have returned -3.4% over the past month, while the Zacks S&P 500 composite increased by +0.7% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Trane Technologies (TT) reported $5.14 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 5.6%. EPS of $2.86 for the same period compares to $2.61 a year ago.The reported revenue represents a surprise of +1.33% over the Zacks Consensus Estimate of $5.08 billion. With the consensus EPS estimate being $2.83, the EPS surprise was +1.24%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to dete ...

Plexus (PLXS) reported $1.07 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 9.6%. EPS of $1.78 for the same period compares to $1.73 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.07 billion, representing a surprise of -0.11%. The company delivered an EPS surprise of +0.57%, with the consensus EPS estimate being $1.77.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...